Related Experiment Videos
Lymphocytic and collagenous colitis: an immunohistochemical study
J F Mosnier1, L Larvol, J Barge
1Service d'Anatomie et de Cytologie Pathologiques, Hôpital Beaujon, Clichy, France.
The American Journal of Gastroenterology
|April 1, 1996
Summary
Immune abnormalities in lymphocytic colitis (LC) and collagenous colitis (CC) are similar, involving increased CD 8 intraepithelial lymphocytes (IELs) and abnormal HLA DR expression. These findings suggest a shared MHC-restricted immune mechanism distinct from celiac disease.
Area of Science:
- Gastroenterology
- Immunology
- Colorectal Pathology
Background:
- Lymphocytic colitis (LC) and collagenous colitis (CC) share increased intraepithelial lymphocytes (IELs).
- Similarities suggest a potential common underlying immune mechanism.
- Investigating IEL and lamina propria lymphocyte phenotypes is crucial.
Purpose of the Study:
- To determine the phenotype of IELs and lamina propria lymphocytes in LC and CC.
- To compare immune cell profiles between LC, CC, and controls.
- To elucidate potential shared pathogenic pathways.
Main Methods:
- Immunohistochemical analysis of colonic and ileal biopsies from LC, CC, and control groups.
- Utilized monoclonal antibodies targeting T-cells (CD4, CD8), HLA DR, and T-cell receptor (TcR) variants (alpha beta, gamma delta).
- Examined IELs and lamina propria lymphocytes across all bowel segments.
Main Results:
- Both LC and CC showed increased IEL counts, with a predominance of CD 8 IELs over CD 4 IELs.
- Most IELs expressed TcR alpha beta; TcR gamma delta-bearing cells were not elevated.
- CD 4+ helper T-cells were predominant in the lamina propria, and epithelial cells abnormally expressed HLA DR antigens.
Conclusions:
- Immune abnormalities in LC and CC are similar, pointing to a potential MHC-restricted immune mechanism.
- Evidence includes CD 4+ T-cell accumulation, CD 8 TcR alpha beta IEL-related epithelial damage, and abnormal HLA DR expression.
- The immune mechanisms in LC/CC likely differ from those in celiac disease.